Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes

NCT01917656 · Completed

Last updated 2026-05-28

This clinical trial compares the effects of liraglutide and sulphonylurea, both taken with metformin, on people with type 2 diabetes during the month of Ramadan.

Status Completed The study has finished.

Phase Phase 4 Monitors a drug already on the market.

Type Interventional (clinical trial)

Design Randomized, open-label (no blinding) treatment study

Participants 343 people

Who can join Ages 18+ · all sexes

Timeline Started 2014-01 · est. completion 2014-09

Where 41 sites · Algeria, India, Israel, Lebanon, Malaysia, South Africa, United Arab Emirates

What this study is testing ClinicalTrials.gov NCT01917656 ↗

Description as written by the study sponsor.

This trial is conducted in Africa and Asia. The aim of the trial is to investigate the efficacy and safety of liraglutide versus sulphonylurea (SU) both in combination with metformin during Ramadan in subjects with type 2 diabetes (T2DM).

Treatments tested

liraglutide Drug

1.8 mg administered subcutaneously (s.c., under the skin) once daily
metformin Drug

Subjects will continue on their pre-trial metformin tablet treatment, dose unchanged
sulphonylurea Drug

Subjects will continue on their pre-trial SU tablet treatment, doses unchanged

Main thing measured	Change in Fructosamine From Start of Ramadan to End of Ramadan
Sponsor	Novo Nordisk A/S
Conditions studied	Diabetes, Diabetes Mellitus, Type 2
GLP-1 drugs	liraglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT01917656 ↗